46-60 of 379

Factors Guiding First-Line Treatment Decisions for Myelofibrosis and Anemia
Project Oncology®Factors Guiding First-Line Treatment Decisions for Myelofibrosis and Anemia

Understanding IL-36 Signaling in GPP and Related Neutrophilic Dermatoses
DermConsultUnderstanding IL-36 Signaling in GPP and Related Neutrophilic Dermatoses

Real-World Outcomes with Axatilimab in cGVHD
Project Oncology®Real-World Outcomes with Axatilimab in cGVHD

Axatilimab’s Impact on cGVHD and Associated BOS
Project Oncology®Axatilimab’s Impact on cGVHD and Associated BOS

A New Era of Generalized Pustular Psoriasis Care
DermConsultA New Era of Generalized Pustular Psoriasis Care
- advertisement

GPP vs. Plaque Psoriasis: Differentiation and Treatment Considerations
DermConsultGPP vs. Plaque Psoriasis: Differentiation and Treatment Considerations

Identifying GPP: Clinical Clues Across Phases
DermConsultIdentifying GPP: Clinical Clues Across Phases

Moving GPP Care Forward: From Awareness to Action
DermConsultMoving GPP Care Forward: From Awareness to Action

Exploring Treatment Strategies in epNEC: The Emerging Role of DLL3
Project Oncology®Exploring Treatment Strategies in epNEC: The Emerging Role of DLL3
- advertisement

Familial Chylomicronemia Syndrome: Improving Recognition and Diagnosis
On the Frontlines of Familial Chylomicronemia SyndromeFamilial Chylomicronemia Syndrome: Improving Recognition and Diagnosis

Early Recognition and Diagnostic Confidence in NTM Lung Disease
Clinician's RoundtableEarly Recognition and Diagnostic Confidence in NTM Lung Disease








































